2seventy bio, China’s JW Therapeutics sign pact for cancer therapy
2seventy bio, Inc., an immuno-oncology cell therapy company, and China’s JW Therapeutics, announced a pact to establish a platform to explore T cell-based
Health
Pharma
Climate
Europe at centre of unequalled energy crisis: IEA
Europe is at the centre of an unprecedented global energy crisis that has significant implications for markets, policies and economies worldwide, according to
Pharma
Glenmark’s India facility gets ‘import alert’ from USFDA
Glenmark Pharmaceuticals, an Indian biopharmaceutical company, has received an "import alert" from USFDA for its Baddi facility in Himachal Pradesh.
Drugs
Pharma
Alembic gets USFDA nod for oncology injection Paclitaxel
Alembic Pharmaceuticals, an Indian maker of generic drugs, announced it had received USFDA's final approval for Paclitaxel injection multi-dose vials for use in
Climate
JSW Steel USA ties up $182 million long-term financing
JSW Steel USA, a $22 billion Indian business conglomerate, has tied-up long-term financing for $182 million to modernise its plate mill facility in
Health
Pharma
Tuberculosis claims 1.6 million people in 2021, WHO says
Tuberculosis, the second deadliest infectious killer after Covid-19, claimed 1.6 million lives last year, including 187,000 HIV-positive patients, according to the WHO's 2022
Climate
Health
Profit-chasing oil companies aid global warming: Lancet
HQ Team October 26, 2022: Global oil and gas companies are clocking record profits while their production strategies undermine people’s lives and well-being
Medical
USFDA approves Zydus Lifesciences anti-fungal injection
USFDA approves Zydus Lifesciences anti-fungal injection HQ Team October 26, 2022: Zydus Lifesciences announced that it had received final approval from the USFDA
Drugs
Pharma
Aurobindo to recall two drugs with potential cancer risk
HQ Team October 26, 2022: Aurobindo Pharma US has initiated a voluntary recall of two lots of tablets in the American market due to the
Pharma
Philips to slash 4,000 jobs as respirator recall slump sales
HQ team Koninklijke Philips N.V., an Amsterdam-based healthcare technology company, plans to slash 4,000 jobs after sales fell following a vast recall of